123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> General >> View Article

Delnova Unveils Partnership With Pace Life Sciences To Boost Capabilities

Profile Picture
By Author: Ben Gross
Total Articles: 433
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

DelNova has announced a strategic partnership with Pace® Life Sciences to serve as their contract development and manufacturing organization (CDMO). This collaboration is aimed at advancing DelNova's candidate Rescue Drug, ReViVox®, designed to address unwanted side effects that may occur after Botulinum Neurotoxin (BoNT) therapy, including well-known US brands like BOTOX®, DYSPORT®, XEOMIN®, and JEUVEAU®.

Pace® Life Sciences brings essential expertise to support DelNova in completing investigational new drug (IND)-enabling research for future FDA submissions. This includes work on formulation, kinetics, and stability. DelNova is actively seeking funding opportunities, both dilutive and non-dilutive, including an application submitted to the Small Business Innovation Research (SBIR) program.

Furthermore, through this partnership with Pace® Life Sciences, DelNova gains the capability to manufacture small Good Manufacturing Practice (GMP) batches of drug products for clinical studies. Pace® Life Sciences, with its specialized CDMO facility in San Diego, excels in complex drug delivery, formulation, and sterile ...
... fill-finish GMP manufacturing.

Mary Gardner, CEO and Founder of DelNova, and Frank Tagliaferri, PhD, Vice President of Pharmaceutical Development at Pace® Life Sciences, are enthusiastic about this collaboration. They bring extensive pharmaceutical development expertise to DelNova's efforts. Currently, there is no available product to reverse unwanted paralysis induced by BoNTs, making ReViVox® potentially the first of its kind to address this medical need.

Pace® Life Sciences is a comprehensive provider of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services for the pharmaceutical, biopharmaceutical, and gene therapy industries. DelNova's ReViVox® is poised to address complications arising from off-target muscle paralysis following aesthetic and medical neurotoxin therapies, filling a crucial void in the industry.

This partnership underscores the commitment of both companies to advance medical solutions and improve patient outcomes in the field of neurotoxin therapy.

More Information : https://www.techdogs.com/tech-news/pr-newswire/delnova-unveils-partnership-with-pace-life-sciences-to-boost-capabilities

Total Views: 77Word Count: 288See All articles From Author

Add Comment

General Articles

1. International School In Malaysia | Top International School In Malaysia
Author: elisha

2. Sonofit™ | Uk Official | #1 New Hearing Formula
Author: rajesh

3. Essential Benefits Of Digital Marketing Efforts
Author: Anthea Johnson

4. Dissatisfaction Of Even Old-time Customers With Amazon India
Author: Yash Kumar

5. Vidmate App Download For Android
Author: vidmate app

6. Finding The Best Seo Company In Mumbai
Author: Siddhi Dheniya

7. Melasma Laser Treatment For Smooth And Even Skin Tone
Author: pavitra

8. Winter Beauty Package At La Femme Hair, Skin & Bridal Salon At La Femme In Satellite, Ahmedabad
Author: lafemmeindia

9. How To Get Your Clients To Make Faster Payments?
Author: Invoice Temple

10. Discover Why We Are The Best Multispeciality Hospital In Jaipur
Author: YATIKA

11. Gutters, Roofing, Windows, And Sidings | What Comes First?
Author: Gutter Empire LLC

12. The Role Of Technology In Outstation Taxi Bookings
Author: RIDEXPRESS

13. Crystalline Designers
Author: Crystalline

14. Wpc Outdoor Wall Panels
Author: karthik

15. The Importance Of Pharma Hcp Engagement In Modern Healthcare
Author: Jesvira

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: